UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by WESPAC Advisors SoCal LLC

WESPAC Advisors SoCal LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the 3rd quarter, Holdings Channel reports. The firm owned 20,474 shares of the healthcare conglomerate’s stock after buying an additional 182 shares during the quarter. UnitedHealth Group makes up about 2.6% of WESPAC Advisors SoCal LLC’s holdings, making the stock its 12th largest holding. WESPAC Advisors SoCal LLC’s holdings in UnitedHealth Group were worth $8,055,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. Anfield Capital Management LLC acquired a new stake in UnitedHealth Group in the second quarter valued at approximately $26,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group in the second quarter worth approximately $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of UnitedHealth Group in the second quarter worth approximately $28,000. Activest Wealth Management acquired a new stake in shares of UnitedHealth Group in the second quarter worth approximately $29,000. Finally, Ten Capital Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 111.6% in the second quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 48 shares during the last quarter. 86.20% of the stock is currently owned by institutional investors.

UNH has been the topic of a number of recent research reports. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price objective on the stock in a research note on Wednesday, October 27th. Evercore ISI boosted their price objective on UnitedHealth Group from $360.00 to $480.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. BMO Capital Markets boosted their price objective on UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a research note on Monday, October 18th. Credit Suisse Group lifted their target price on UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. Finally, Cowen assumed coverage on UnitedHealth Group in a research report on Thursday, September 9th. They issued an “outperform” rating and a $478.00 target price on the stock. One investment analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $477.35.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the stock in a transaction on Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction on Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total value of $1,041,875.00. Following the completion of the transaction, the director now directly owns 154,403 shares in the company, valued at $64,347,450.25. The disclosure for this sale can be found here. Over the last three months, insiders sold 82,500 shares of company stock valued at $36,855,125. Insiders own 0.55% of the company’s stock.

Shares of NYSE:UNH traded up $3.03 on Thursday, hitting $450.16. 2,248,836 shares of the company’s stock were exchanged, compared to its average volume of 2,940,181. The firm’s 50-day moving average is $430.47 and its 200 day moving average is $418.01. The company has a market capitalization of $423.98 billion, a PE ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a 1-year low of $320.35 and a 1-year high of $466.00. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.77 and a current ratio of 0.77.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.51 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be given a $1.45 dividend. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.29%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.98%.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

See Also: Outstanding Shares

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.